"Comprehensive Meta‐Analysis is, in my view, the best meta‐analysis software on the market and a "must have" for any meta‐analyst. Before I used this software, I was convinced that specialized metaanalysis software was not necessary at all. At that time, I used my own Excel spreadsheets and SPSS to run meta‐analysis. In fact, I only tried CMA because I needed a way to make forest plots. Once I tried it, however, I was sold. I could not believe how user friendly it was and how much it could do. Suddenly not only was meta‐analysis more efficient, but, more importantly, I could run all types of analyses that previously were not available with the software I had been using. I have since used the program to conduct and publish several meta‐analyses. Given how great the program is, I require it when I teach my graduate meta‐analysis seminar. Students always seem surprised when they see how easy it is to use, as this is certainly not the norm in statistical software. Thus, our graduate students seem to greatly value CMA as a key resource for conducting meta‐analysis."

Seth M. Noar, Ph.D. - Professor, Hussman School of Journalism and Media, University of North Carolina at Chapel Hill

"The program in Comparative Effectiveness and Outcomes Research at Duke University conducts multiple systematic reviews and meta‐analyses each year for professional organizations as well as under both federal and industry sponsored research initiatives. While we use various programs tailored for specific individual projects including those developed in‐house, we have found Comprehensive Meta‐Analysis (CMA) to be a very facile, adaptable and yet comprehensive package meeting the needs for much of our research and generating publication‐quality graphics. My confidence in the analytic algorithms is buoyed by my knowledge of several of the developers of CMA and based on extensive comparison of results with other algorithms including our own. CMA is also an exceptional educational tool and universally embraced by trainees and young investigators initiating careers in evidence‐based medicine and statistical analysis."

Gary H Lyman, MD, MPH, FRCP (Edin) - Professor of Medicine and Director, Comparative Effectiveness and Outcomes Research, Duke University School of Medicine, and the Duke Comprehensive Cancer Center, Senior Fellow, Duke Center for Clinical Health Policy Research, Durham, NC